Results of an open clinical trial of brofaromine (CGP 11 305 A), a competitive, selective, and short-acting inhibitor of MAO-A in major endogenous depression.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples